Recommendation ID

Further research is recommended to assess the diagnostic yield of the BioMonitor 2‑AF and Confirm Rx (or later devices) for atrial fibrillation when used in people who have had a cryptogenic stroke. The committee noted that existing ongoing research may provide further data for these devices (see section 3.51 and section 4.19).

Any explanatory notes
(if applicable)

Source guidance details

Comes from guidance
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke
Date issued
September 2020

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 26/08/2020